Philips Recall Update: October 15, 2021

 The email below was sent to Philips’ CPAP users on October 15, 2022

We are pleased to share an important update regarding your Philips device replacement. Philips received authorization from the US Food and Drug Administration (FDA) for the repair and replacement program for devices impacted by the June 14, 2021 recall notification*.

With this approval, we are initiating the repair and replacement program that puts patient safety and speed of resolution as the top priorities. Further, we have significantly increased our production, service and rework capacity to deliver replacement devices as fast as possible.

Also, we have learned of some fraudulent activity targeting patients impacted by this recall. We want to assure you that Philips will never ask for any payment or credit card information by phone or email.

Patient care is at the heart of everything we do at Philips. While we are starting to replace devices, in some cases, this process may take approximately 12 months. We will stay in communication with you regarding your replacement device. If you have already received a replacement device, please follow the instructions included in the box.

We appreciate your patience as we work towards a solution as fast as possible. Please visit for more information and answers to frequently asked questions.

Thank you for your continued trust.

*This is a recall notification for the US only, and a field safety notice for the rest of the world. In the US, the recall notification has been classified by the FDA as a Class I recall. Devices authorized for repair and replacement include DreamStation CPAP and BiLevel devices, DreamStation ASV devices, and DreamStation ST/AVAPS devices.

** For more information and continued updates, visit

Be the first to comment

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.